Concepedia

Keighley Reisenauer

KR

6

Publications

154

Citations

6

H-Index

2017

Active since

Affiliations

Baylor University(Current)

University of Naples Federico II

Keighley Reisenauer is an author at Baylor University specializing in drug discovery, medicinal chemistry, and natural sciences.

ORCID

Top concepts

Publications per year

2017–2021

6

Publications

6

The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition

Joseph H. Taube, Nathalie Sphyris, Kelsey S. Johnson et al. · Oncotarget · 2017 · 66 citations · Full text

Pharmacophore-Directed Retrosynthesis Applied to Ophiobolin A: Simplified Bicyclic Derivatives Displaying Anticancer Activity

Yongfeng Tao, Keighley Reisenauer, Marco Masi et al. · Organic Letters · 2020 · 28 citations · Full text

, , +14

Total Synthesis and Anticancer Activity of (+)‐Hypercalin C and Congeners

Yongfeng Tao, Keighley Reisenauer, Joseph H. Taube et al. · Angewandte Chemie International Edition · 2019 · 19 citations · Full text

Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A

Keighley Reisenauer, Yongfeng Tao, Provas Das et al. · Scientific Reports · 2021 · 17 citations · Full text

Staurosporine Analogs Via C–H Borylation

Kevin M. Gayler, Ke Kong, Keighley Reisenauer et al. · ACS Medicinal Chemistry Letters · 2020 · 14 citations · Full text

, , +15

Rows per page

1–5 of 6